2929 — Pharma Foods International Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual income statement for Pharma Foods International Co, fiscal year end - July 31st, JPY millions except per share, conversion factor applied.

	2020 July 31st	2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	15,353	46,752	60,185	68,572	62,147
Cost of Revenue
Gross Profit	12,175	39,725	48,108	55,279	48,752
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	14,554	41,080	59,023	65,004	57,259
Operating Profit	800	5,672	1,162	3,568	4,888
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	849	5,765	1,423	3,542	5,034
Provision for Income Taxes
Net Income After Taxes	691	3,841	-374	3,080	3,206
Minority Interest
Net Income Before Extraordinary Items
Net Income	691	3,841	-374	3,080	3,206
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	691	3,841	-374	3,081	3,205
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	23.4	134	-14.7	111	121
Dividends per Share
Special Dividends per Share